Markston International’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $368K | Sell |
6,225
-766
| -11% | -$38K | 0.37% | 53 |
|
|
2021
Q3 | $301K | Sell |
6,991
-24,058
| -77% | -$1.07M | 0.28% | 62 |
|
|
2021
Q2 | $1.22M | Sell |
31,049
-109,085
| -78% | -$4.24M | 0.74% | 37 |
|
|
2021
Q1 | $5.08M | Sell |
140,134
-4,508
| -3% | -$160K | 0.57% | 50 |
|
|
2020
Q4 | $5.32M | Sell |
144,642
-15,162
| -9% | -$556K | 0.63% | 46 |
|
|
2020
Q3 | $5.56M | Sell |
159,804
-38,454
| -19% | -$1.35M | 0.71% | 41 |
|
|
2020
Q2 | $6.15M | Sell |
198,258
-15,168
| -7% | -$515K | 0.72% | 40 |
|
|
2020
Q1 | $6.61M | Sell |
213,426
-72
| -0% | -$2.45K | 0.92% | 39 |
|
|
2019
Q4 | $7.94M | Buy |
213,498
+1,939
| +0.9% | +$69.1K | 0.82% | 42 |
|
|
2019
Q3 | $7.21M | Buy |
211,559
+29,907
| +16% | +$1.09M | 0.81% | 42 |
|
|
2019
Q2 | $7.47M | Buy |
181,652
+3,023
| +2% | +$120K | 0.87% | 41 |
|
|
2019
Q1 | $7.2M | Sell |
178,629
-137
| -0.1% | -$5.49K | 0.84% | 43 |
|
|
2018
Q4 | $7.4M | Sell |
178,766
-12,648
| -7% | -$525K | 0.95% | 40 |
|
|
2018
Q3 | $8M | Hold |
191,414
| – | – | 0.86% | 44 |
|
|
2018
Q2 | $7.25M | Sell |
191,414
-2,217
| -1% | -$75.8K | 0.78% | 48 |
|
|
2018
Q1 | $6.52M | Sell |
193,631
-5,978
| -3% | -$206K | 0.7% | 54 |
|
|
2017
Q4 | $6.86M | Sell |
199,609
-3,672
| -2% | -$125K | 0.71% | 55 |
|
|
2017
Q3 | $6.89M | Sell |
203,281
-5,699
| -3% | -$183K | 0.71% | 55 |
|
|
2017
Q2 | $6.66M | Sell |
208,980
-4,665
| -2% | -$147K | 0.65% | 60 |
|
|
2017
Q1 | $6.93M | Sell |
213,645
-727
| -0.3% | -$22.9K | 0.68% | 59 |
|
|
2016
Q4 | $6.61M | Sell |
214,372
-10,595
| -5% | -$323K | 0.63% | 64 |
|
|
2016
Q3 | $7.23M | Buy |
224,967
+15,622
| +7% | +$522K | 0.68% | 58 |
|
|
2016
Q2 | $6.99M | Sell |
209,345
-8,415
| -4% | -$269K | 0.66% | 60 |
|
|
2016
Q1 | $6.12M | Buy |
217,760
+790
| +0.4% | +$22.6K | 0.58% | 67 |
|
|
2015
Q4 | $6.64M | Buy |
216,970
+527
| +0.2% | +$16.6K | 0.57% | 68 |
|
|
2015
Q3 | $6.45M | Buy |
216,443
+17,155
| +9% | +$550K | 0.57% | 70 |
|
|
2015
Q2 | $6.34M | Sell |
199,288
-2,724
| -1% | -$88.8K | 0.47% | 78 |
|
|
2015
Q1 | $6.67M | Buy |
202,012
+3,812
| +2% | +$121K | 0.45% | 78 |
|
|
2014
Q4 | $5.86M | Sell |
198,200
-348
| -0.2% | -$9.98K | 0.36% | 93 |
|
|
2014
Q3 | $5.57M | Buy |
198,548
+8,379
| +4% | +$235K | 0.34% | 95 |
|
|
2014
Q2 | $5.36M | Sell |
190,169
-211
| -0.1% | -$6.01K | 0.32% | 98 |
|
|
2014
Q1 | $5.8M | Sell |
190,380
-632
| -0.3% | -$18.8K | 0.36% | 91 |
|
|
2013
Q4 | $5.55M | Sell |
191,012
-20,026
| -9% | -$583K | 0.35% | 90 |
|
|
2013
Q3 | $5.75M | Sell |
211,038
-12,121
| -5% | -$330K | 0.39% | 88 |
|
|
2013
Q2 | $5.93M | Buy |
+223,159
| New | +$6.17M | 0.39% | 87 |
|
Other funds holding PFE
Markston International's PFE Position: Q4 2021 in Review
Markston International reduced its Pfizer (PFE) stake by 11% in Q4 2021, selling an estimated $38K and leaving 6,225 shares worth $368K. The position accounts for 0.37% of the portfolio, ranked #53.
Markston International first reported a position in PFE in Q2 2013 and has held it in 35 quarters since. The position peaked at $8M in Q3 2018. 3,263 funds tracked by Wall St. Rank hold PFE as of Q4 2021.
- Markston International held 6,225 shares of Pfizer worth $368K as of Q4 2021.
- Markston International sold 766 Pfizer shares in Q4 2021, an estimated $38K.
- Pfizer made up 0.37% of Markston International's portfolio in Q4 2021, its #53 holding.
- Markston International first reported a position in Pfizer in Q2 2013 and has held it in 35 quarters since.
- Markston International's Pfizer position peaked at $8M in Q3 2018.
- 3,263 funds tracked by Wall St. Rank held Pfizer as of Q4 2021.
Based on Markston International's 13F filing for Q4 2021, filed 21 Jan 2022.